Crossmark

Restricting α-synuclein transport into mitochondria by inhibition of α-synuclein–VDAC complexation as a potential therapeutic target for Parkinson’s disease treatment

Crossref DOI link: https://doi.org/10.1007/s00018-022-04389-w

Published Online: 2022-06-19

Published Print: 2022-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rajendran, Megha

Queralt-Martín, María

Gurnev, Philip A.

Rosencrans, William M.

Rovini, Amandine

Jacobs, Daniel

Abrantes, Kaitlin

Hoogerheide, David P.

Bezrukov, Sergey M.

Rostovtseva, Tatiana K. https://orcid.org/0000-0001-7299-7362
Funding

Funding for this research was provided by:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (ZIA HD 000072)

Spanish Ministry of Science and Innovation (IJC2018-035283-I)

Universitat Jaume I (UJI-A2020-21)
License Information

Text and Data Mining valid from 2022-06-19

Version of Record valid from 2022-06-19
More Information

Article History

Received: 14 March 2022

Revised: 13 May 2022

Accepted: 20 May 2022

First Online: 19 June 2022

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below